Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients

Transplantation Proceedings

Volumn 43, Issue 4, 2011, Pages 1159-1161

  Costa, C ^a   Astegiano, S ^a   Terlizzi, M E ^a   Sidoti, F ^a   Curtoni, A ^a   Solidoro, P ^b   Baldi, S ^b   Bergallo, M ^a   Cavallo, R ^a  

^a Azienda Ospedaliero   (Italy)

^b Divisione di Pneumologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; GANCICLOVIR; VALGANCICLOVIR; VIRUS DNA;

ACUTE GRAFT REJECTION; ADULT; AGED; ANTIVIRAL THERAPY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONFERENCE PAPER; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD; VIRUS PNEUMONIA; VIRUS REPLICATION;

ADULT; AGED; ANTIVIRAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CHI-SQUARE DISTRIBUTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; ITALY; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MONITORING, IMMUNOLOGIC; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 79957598914     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.03.024     Document Type: Conference Paper

References (8)

1. Rhada RS, Jordan D, Puliyanda S, et al: Cellular immune responses to citomegalovirus in renal transplant recipients. Am J Transplant 5:110, 2005
2. Shlobin OA, West EE, Lechtzin N, et al: Persistent cytomegalovirus- specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients. J Immunol 176:2625, 2006
3. Chiereghin A, Gabrielli L, Zanfi C, et al: Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. Transplant Proc 42:69, 2010
4. Zhang W, Caspell R, Karulin AY, et al: Elispot assays provide reproducible results among different laboratories for T-cell immune monitoring - even in hands of Elispot-inexperienced investigators. J Immunotoxicol 6:227, 2009
5. Costa C, Delsedime L, Solidoro P, et al: Herpesviruses detection by quantitative real-time polymerase chain reaction in bronchoalveolar lavage and transbronchial biopsy in lung transplant: viral infections and histopathological correlation. Transplant Proc 42:1270, 2010
6. Terlizzi ME, Astegiano S, Sidoti F, et al: Development of an Elispot assay for detection of CMV- specific immune response. Microbiologia Medica 25:130, 2010
7. Christie JD, Edwards LB, Aurora P, et al: Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report - 2008. J Heart Lung Transplant 27:957, 2008
8. Sester U, Gärtner BC, Wilkens H, et al: Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation. Am J Transplant 5:1483, 2005.